Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 5 2015

Print RSS Feed

Search Results for 'Financial Reports: Biogen Idec'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published March 23, 2015
Introduces new corporate identity and logo Read More »
Published January 30, 2015
MS portfolio drives growth Read More »
Published October 22, 2014
Revenues up 37% as TECFIDERA sales soar Read More »
Published April 23, 2014
51% growth driven by MS franchise Read More »
Published October 25, 2012
Revenues up 6% in the quarter on Avonex boost Read More »
Published July 24, 2012
Revenues up 18% in the quarter Read More »
Published February 6, 2009
Growth was driven by Tysabri sales, up 74% to $156 million in the quarter and up 156% to $589 million for the year. Read More »
Published October 21, 2008
Biogen Idec 3Q Revenues: $1.1 billion (+38%) 3Q Earnings: $207 million (+74%) YTD Revenues: $3.0 billion (+33%) YTD Earnings: $576.5 million (+32%) Comments: Tysabri sales recorded by Biogen, based on its collaboration with Elan, were… Read More »
Published July 22, 2008
Biogen Idec 2Q Revenues: $993 million (+28%) 2Q Earnings: $207 million (+11%) YTD Revenues: $1.9 billion (+30%) YTD Earnings: $369.7 million (+16%) Comments: Growth in the quarter was driven by Avonex sales up 14% to $527 million, Tysa… Read More »
Newsmakers: Margaret Timony
Published March 6, 2015
What’s Happening at DCAT Week ’15? Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On